These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 8294097

  • 1. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
    Mason WS, Cullen J, Saputelli J, Wu TT, Liu C, London WT, Lustbader E, Schaffer P, O'Connell AP, Fourel I.
    Hepatology; 1994 Feb; 19(2):398-411. PubMed ID: 8294097
    [Abstract] [Full Text] [Related]

  • 2. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
    Fourel I, Cullen JM, Saputelli J, Aldrich CE, Schaffer P, Averett DR, Pugh J, Mason WS.
    J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
    [Abstract] [Full Text] [Related]

  • 3. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY, Cheng AC, Wang MS, Xu DW, Zeng W, Li Z.
    Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
    [Abstract] [Full Text] [Related]

  • 4. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS, Boyle D, Feng F, Reaiche GY, Kotlarski I, Colonno R, Jilbert AR.
    Virology; 2008 Apr 10; 373(2):329-41. PubMed ID: 18206204
    [Abstract] [Full Text] [Related]

  • 5. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
    Hu Q, Fang Y, Zhang ZM, Zhang XY, Zhang ZH, Yang DL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr 10; 22(2):113-5. PubMed ID: 18574531
    [Abstract] [Full Text] [Related]

  • 6. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.
    Luscombe C, Pedersen J, Uren E, Locarnini S.
    Hepatology; 1996 Oct 10; 24(4):766-73. PubMed ID: 8855174
    [Abstract] [Full Text] [Related]

  • 7. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
    Reaiche GY, Le Mire MF, Mason WS, Jilbert AR.
    Virology; 2010 Oct 25; 406(2):286-92. PubMed ID: 20705309
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
    Schorr O, Borel C, Trepo C, Zoulim F, Hantz O.
    J Hepatol; 2006 May 25; 44(5):842-7. PubMed ID: 16458387
    [Abstract] [Full Text] [Related]

  • 10. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
    Soni PN, Brown D, Saffie R, Savage K, Moore D, Gregoriadis G, Dusheiko GM.
    Hepatology; 1998 Nov 25; 28(5):1402-10. PubMed ID: 9794928
    [Abstract] [Full Text] [Related]

  • 11. Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture.
    Ying C, Tan S, Cheng YC.
    Antivir Chem Chemother; 2010 Nov 25; 21(2):97-103. PubMed ID: 21107018
    [Abstract] [Full Text] [Related]

  • 12. [Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo].
    Chen G, Chen J, Liu D, Zhang X, Zhu C, Li Y, Wang L, Yang Y, Cai G, Han F.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec 25; 11(4):329-32. PubMed ID: 15617240
    [Abstract] [Full Text] [Related]

  • 13. Characterisation of the Indian strain of duck hepatitis B virus (DHBV) and development of a carrier duck colony for antiviral drug testing.
    Munshi A, Mehrotra R, Panda SK.
    Trop Gastroenterol; 1994 Dec 25; 15(2):77-85. PubMed ID: 7831721
    [Abstract] [Full Text] [Related]

  • 14. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
    Tsiquaye KN, Slomka MJ, Maung M.
    J Med Virol; 1994 Mar 25; 42(3):306-10. PubMed ID: 8006644
    [Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica.
    Han YQ, Huang ZM, Yang XB, Liu HZ, Wu GX.
    J Ethnopharmacol; 2008 Jun 19; 118(1):148-53. PubMed ID: 18495393
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Inhibitory effect of trisodium phosphonoformate (PFA) on duck hepatitis B virus (DHBV) DNA in vivo].
    Chen X, Chen H.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 19; 11(3):277-81. PubMed ID: 15617348
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
    Zhao G, Yin Z, Dong J.
    J Ethnopharmacol; 2009 Sep 07; 125(2):265-8. PubMed ID: 19580857
    [Abstract] [Full Text] [Related]

  • 20. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
    Zoulim F, Dannaoui E, Borel C, Hantz O, Lin TS, Liu SH, Trépo C, Cheng YC.
    Antimicrob Agents Chemother; 1996 Feb 07; 40(2):448-53. PubMed ID: 8834896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.